Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer's Disease Patients Alter Calcium Homeostasis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Rubio Moscardo, Fanny ^a   Setó Salvia, Núria ^b   Pera, Marta ^b   Bosch Morató, Mònica ^a   Plata, Cristina ^a   Belbin, Olivia ^b,c   Gené, Gemma ^a   Dols Icardo, Oriol ^b,c   Ingelsson, Martin ^d   Helisalmi, Seppo ^e   Soininen, Hilkka ^e   Hiltunen, Mikko ^e   Giedraitis, Vilmantas ^d   Lannfelt, Lars ^d   Frank, Ana ^c,f   Bullido, MJesús ^c,f,g   Combarros, Onofre ^c,h   Sánchez Juan, Pascual ^c,h   Boada, Mercè ^i,j   Tárraga, Lluís ⁱ   Pastor, Pau ^c,k   Pérez Tur, Jordi ^c,l   Baquero, Miquel ^m   Molinuevo, José L ⁿ   Sánchez Valle, Raquel ⁿ   Fuentes Prior, Pablo ^o   Fortea, Juan ^b,c   Blesa, Rafael ^b,c   Muñoz, Francisco J ^a   Lleó, Alberto ^b,c   Valverde, Miguel A ^a   Clarimón, Jordi ^b,c   more..

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d UPPSALA UNIVERSITY   (Sweden)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ Institut Catala de Neurociencies Aplicades   (Spain)

^j HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^k UNIVERSITY OF NAVARRA   (Spain)

^l INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^m HOSPITAL UNIVERSITARIO LA FE   (Spain)

ⁿ INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^o HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM; CALCIUM CHANNEL;

ADULT; ALZHEIMER DISEASE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; FINLAND; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MEMBRANE PERMEABILITY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; SPAIN; SWEDEN; WILD TYPE;

ADULT; AGE OF ONSET; AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; HOMEOSTASIS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; SEQUENCE ALIGNMENT;

EID: 84884237148     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074203     Document Type: Article

References (38)

1. Berridge MJ, Bootman MD, Roderick HL, (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529. doi:10.1038/nrm1155. PubMed: 12838335.
2. Catterall WA, Few AP, (2008) Calcium channel regulation and presynaptic plasticity. Neuron 59: 882-901. doi:10.1016/j.neuron.2008.09.005. PubMed: 18817729.
3. Khachaturian ZS, (1987) Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol Aging 8: 345-346. doi:10.1016/0197-4580(87)90073-X. PubMed: 3627349.
4. LaFerla FM, (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3: 862-872. doi:10.1038/nrg930. PubMed: 12415294.
5. Mattson MP, (2007) Calcium and neurodegeneration. Aging Cell 6: 337-350. doi:10.1111/j.1474-9726.2007.00275.x. PubMed: 17328689.
6. Etcheberrigaray R, Hirashima N, Nee L, Prince J, Govoni S, et al. (1998) Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol Dis 5: 37-45. doi:10.1006/nbdi.1998.0176. PubMed: 9702786.
7. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, et al. (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5: 101-106. doi:10.1038/4789. PubMed: 9883847.
8. Larson J, Lynch G, Games D, Seubert P, (1999) Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res 840: 23-35. doi:10.1016/S0006-8993(99)01698-4. PubMed: 10517949.
9. Leissring MA, Akbari Y, Fanger CM, Cahalan MD, Mattson MP, et al. (2000) Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J Cell Biol 149: 793-798. doi:10.1083/jcb.149.4.793. PubMed: 10811821.
10. Garwood C, Faizullabhoy A, Wharton SB, Ince PG, Heath P, et al. (2013) Calcium dysregulation in relation to Alzheimer-type pathology in the ageing brain. Neuropathol Appl Neurobiol [Epub ahead of print]. PubMed: 23421725.
11. Cheung KH, Shineman D, Müller M, Cárdenas C, Mei L, et al. (2008) Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 58: 871-883. doi:10.1016/j.neuron.2008.04.015. PubMed: 18579078.
12. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, et al. (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59: 214-225. doi:10.1016/j.neuron.2008.06.008. PubMed: 18667150.
13. Veinbergs I, Everson A, Sagara Y, Masliah E, (2002) Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis. J Neurosci Res 67: 379-387. doi:10.1002/jnr.10138. PubMed: 11813243.
14. Yoo AS, Cheng I, Chung S, Grenfell TZ, Lee H, et al. (2000) Presenilin-mediated modulation of capacitative calcium entry. Neuron 27: 561-572. doi:10.1016/S0896-6273(00)00066-0. PubMed: 11055438.
15. Supnet C, Bezprozvanny I, (2011) Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. Cell Calcium 50: 303-309. doi:10.1016/j.ceca.2011.05.013. PubMed: 21663966.
16. Nelson O, Supnet C, Liu H, Bezprozvanny I, (2010) Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes. J Alzheimers Dis 21: 781-793. PubMed: 20634584.
17. Dreses-Werringloer U, Lambert JC, Vingtdeux V, Zhao H, Vais H, et al. (2008) A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell 133: 1149-1161. doi:10.1016/j.cell.2008.05.048. PubMed: 18585350.
18. Gallego-Sandín S, Alonso MT, García-Sancho J, (2011) Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress. Biochem J 437: 469-475. doi:10.1042/BJ20110479. PubMed: 21574960.
19. Moreno-Ortega AJ, Ruiz-Nuno A, Garcia AG, Cano-Abad MF, (2010) Mitochondria sense with different kinetics the calcium entering into HeLa cells through calcium channels CALHM1 and mutated P86L-CALHM1. Biochem Biophys Res Commun 391: 722-726.
20. Ma Z, Siebert AP, Cheung KH, Lee RJ, Johnson B, et al. (2012) Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an ion channel that mediates extracellular Ca2+ regulation of neuronal excitability. Proc Natl Acad Sci U S A 109: E1963-E1971. doi:10.1073/pnas.1204023109. PubMed: 22711817.
21. Lambert JC, Sleegers K, González-Pérez A, Ingelsson M, Beecham GW, et al. (2010) The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis 22: 247-255. PubMed: 20847397.
22. Boada M, Antúnez C, López-Arrieta J, Galán JJ, Morón FJ, et al. (2010) CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model. J Alzheimers Dis 20: 247-251. PubMed: 20164592.
23. Minster RL, Demirci FY, DeKosky ST, Kamboh MI, (2009) No association between CALHM1 variation and risk of Alzheimer disease. Hum Mutat 30: E566-E569. doi:10.1002/humu.20989. PubMed: 19191331.
24. Sleegers K, Brouwers N, Bettens K, Engelborghs S, van Miegroet H, et al. (2009) No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Hum Mutat 30: E570-E574. doi:10.1002/humu.20990. PubMed: 19191332.
25. Bertram L, Schjeide BM, Hooli B, Mullin K, Hiltunen M, et al. (2008) No association between CALHM1 and Alzheimer's disease risk. Cell 135: 993-996; author reply 10.1016/j.cell.2008.11.030. PubMed: 19070563.
26. Guerreiro RJ, Baquero M, Blesa R, Boada M, Brás JM, et al. (2010) Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging 31: 725-731. doi:10.1016/j.neurobiolaging.2008.06.012. PubMed: 18667258.
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944. doi:10.1212/WNL.34.7.939. PubMed: 6610841.
28. Ferrer-Costa C, Orozco M, de la Cruz X, (2004) Sequence-based prediction of pathological mutations. Proteins 57: 811-819. doi:10.1002/prot.20252. PubMed: 15390262.
29. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129-2141. doi:10.1101/gr.772403. PubMed: 12952881.
30. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249. doi:10.1038/nmeth0410-248. PubMed: 20354512.
31. Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, et al. (1988) Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A 85: 7341-7345. doi:10.1073/pnas.85.19.7341. PubMed: 3140239.
32. Guardia-Laguarta C, Coma M, Pera M, Clarimón J, Sereno L, et al. (2009) Mild cholesterol depletion reduces amyloid-beta production by impairing APP trafficking to the cell surface. J Neurochem 110: 220-230. doi:10.1111/j.1471-4159.2009.06126.x. PubMed: 19457132.
33. Fernandes J, Lorenzo IM, Andrade YN, Garcia-Elias A, Serra SA, et al. (2008) IP3 sensitizes TRPV4 channel to the mechano- and osmotransducing messenger 5'-6'-epoxyeicosatrienoic acid. J Cell Biol 181: 143-155. doi:10.1083/jcb.200712058. PubMed: 18378772.
34. Coma M, Guix FX, Ill-Raga G, Uribesalgo I, Alameda F, et al. (2008) Oxidative stress triggers the amyloidogenic pathway in human vascular smooth muscle cells. Neurobiol Aging 29: 969-980. doi:10.1016/j.neurobiolaging.2007.01.009. PubMed: 17306421.
35. Muñoz FJ, Opazo C, Gil-Gómez G, Tapia G, Fernández V, et al. (2002) Vitamin E but not 17beta-estradiol protects against vascular toxicity induced by beta-amyloid wild type and the Dutch amyloid variant. J Neurosci 22: 3081-3089. PubMed: 11943811.
36. Mattson MP, (2010) ER calcium and Alzheimer's disease: in a state of flux. Sci Signal 3: e10.
37. Penzes P, Vanleeuwen JE, (2011) Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease. Brain. Res Rev 67: 184-192. doi:10.1016/j.brainresrev.2011.01.003.
38. Sheng M, Sabatini BL, Sudhof TC, (2012) Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol 4.